Edition: Global  
One News Page
“Probably the fastest-access news portal in the world”
> >

Some Teenagers Recreated Martin Shkreli's Crazy-Expensive Drug For $20

Huffington Post Thursday, 1 December 2016
When Martin Shkreli, the former CEO of Turing Pharmaceuticals, hiked up the price of a life-saving medication, one group of high school students saw an opportunity to do good.

Eight teenagers from Sydney Grammar School in Australia have collaborated with scientists from the University of Sydney to reproduce the active...
0
shares
Share on
Facebook
Share on
Twitter
Post on 
Reddit
Share by
Email
 
Source: Newsy Studio - < > Embed

News video: Teenagers Recreate $750 Martin Shkreli Drug for $2 a Dose

Teenagers Recreate $750 Martin Shkreli Drug for $2 a Dose 01:16

A group of Australian students say they recreated the active ingredient in life-saving drug Daraprim for a fraction of its U.S. price.

You Might Like


Other recent news in World

Ahead of ASEAN summit, Philippines president Rodrigo Duterte says SOUTH CHINA SEA row is 'better left untouched'Thorny SOUTH CHINA Sea likely to dominate ASEAN summit
Donald Trump offers to mediate in South CHINA SEA feud while China continues to downplay Beijing's military buildup in regionASEAN summit in Manila: Narendra Modi, DONALD TRUMP likely to have bilateral meet tomorrow
Philippines: People protest "Dump Trump" in Manila ahead of ASEAN SUMMITDonald Trump insulted by Kim Jong-Un calling him 'old', vows to never call North Korean leader 'short and fat'
Remembrance Sunday: PRINCE CHARLES lays Cenotaph wreath'He's being played by Vladimir Putin': Donald Trump backtracks on RUSSIA hack
President Donald Trump has arrived in the PHILIPPINES, final stop on a five-country tour of AsiaMay could face a defeat on BREXIT Bill on meaningful vote

Twitter

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2017 One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+